Dysregulated responsiveness of circulating dendritic cells to Toll-like receptors in ANCA-associated vasculitis, Front Immunol, vol.8, p.102, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02156159
Persistent deficiency of circulating mucosalassociated invariant T (MAIT) cells in ANCA-associated vasculitis, J Autoimmun, vol.70, pp.73-82, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02150784
Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention, Am J Kidney Dis, vol.62, pp.1176-87, 2013. ,
Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibodyassociated vasculitis, PLoS One, vol.6, p.18734, 2011. ,
A CD8+ T cell transcription signature predicts prognosis in autoimmune disease, Nat Med, vol.16, pp.586-91, 2010. ,
CD8+ T cells effect glomerular injury in experimental anti-myeloperoxidase GN, J Am Soc Nephrol, vol.28, pp.47-55, 2017. ,
for the French Vasculitis Study Group. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis, N Engl J Med, vol.371, pp.1771-80, 2014. ,
Rituximab versus cyclophosphamide for ANCA-associated vasculitis, N Engl J Med, vol.363, pp.221-253, 2010. ,
A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus, J Exp Med, vol.189, pp.1639-1687, 1999. ,
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells, J Exp Med, vol.209, pp.1001-1011, 2012. ,
Effector and regulatory B cells: modulators of CD4+ T cell immunity, Nat Rev Immunol, vol.10, pp.236-283, 2010. ,
Circulating T follicular helper cell and regulatory T cell frequencies are influenced by B cell depletion in patients with granulomatosis with polyangiitis, Rheumatology (Oxford), vol.53, pp.621-651, 2014. ,
CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner, Eur J Immunol, vol.43, pp.2043-54, 2013. ,
CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines, Blood, vol.121, pp.2647-58, 2013. ,
Expression of Helios, an Ikaros transcription factor family member, differentiates thymicderived from peripherally induced Foxp3+ T regulatory cells, J Immunol, vol.185, p.7129, 2010. ,
Helios enhances Treg cell function in cooperation with FoxP3, Arthritis Rheumatol, vol.67, pp.1491-502, 2015. ,
Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells, J Immunol, vol.184, pp.3433-3474, 2010. ,
CD4+CD28? T cell expansion in granulomatosis with polyangiitis (Wegener's) is driven by latent cytomegalovirus infection and is associated with an increased risk of infection and mortality, Arthritis Rheum, vol.63, pp.2127-2164, 2011. ,
Expansions of CD4+CD28? and CD8+CD28? T cells in granulomatosis with polyangiitis and microscopic polyangiitis are associated with cytomegalovirus infection but not with disease activity, J Rheumatol, vol.39, pp.1840-1843, 2012. ,
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab, Blood, vol.112, pp.1147-50, 2008. ,
The anti-CD20 antibody rituximab reduces the Th17 cell response, Arthritis Rheum, vol.63, pp.1507-1523, 2011. ,
B cell depletion therapy normalizes circulating follicular Th cells in primary Sjögren syndrome, J Rheumatol, vol.44, pp.49-58, 2017. ,
Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission, Arthritis Rheum, vol.56, pp.2080-91, 2007. ,
Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells, Immunology, vol.130, pp.64-73, 2010. ,
Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population, Arthritis Rheum, vol.65, pp.1922-1955, 2013. ,
Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis, Blood, vol.111, pp.5334-5375, 2008. ,
Frequency of regulatory T cells is not affected by transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis, Open Rheumatol J, vol.2, pp.81-89, 2008. ,
Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis, Immunology, vol.142, pp.354-62, 2014. ,
Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study, Arthritis Res Ther, vol.8, p.83, 2006. ,
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE, Clin Immunol, vol.122, pp.62-74, 2007. ,
Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor, Immunity, vol.30, pp.899-911, 2009. ,
Anti-CD20 therapy induces a memory Th1 response through the IFN-?/IL-12 axis and prevents protumor regulatory T-cell expansion in mice, Leukemia, vol.29, pp.947-57, 2015. ,
Anti-perforin antibody treatment ameliorates experimental crescentic glomerulonephritis in WKY rats, Kidney Int, vol.72, pp.823-853, 2007. ,
Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis, J Am Soc Nephrol, vol.13, pp.359-69, 2002. ,
Rituximab exerts a dual effect in pemphigus vulgaris, J Invest Dermatol, vol.128, pp.2850-2858, 2008. ,
B cell biomarkers of rituximab responses in systemic lupus erythematosus, Arthritis Rheum, vol.63, pp.3038-3085, 2011. ,
Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis, Arthritis Rheum, vol.58, pp.2993-3002, 2008. ,
Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions, Ann Rheum Dis, vol.74, pp.1734-1742, 2015. ,
, , p.5
, + B cells in active ANCA vasculitis and relapse after rituximab, Clin J Am Soc Nephrol, vol.8, pp.382-91, 2013.
Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis, Ann Rheum Dis, vol.74, pp.1784-1790, 2015. ,
, Applications Invited for Arthritis & Rheumatology Editor-in-Chief, 2020.
, ACR members who are considering applying should submit a nonbinding letter of intent by May 1, 2019 to the Managing Editor, Jane Diamond, at jdiamond@rheumatology.org, and are also encouraged to contact the current Editor-in-Chief, Dr. Richard Bucala, to discuss details; initial contact should be made via e-mail to richard, The American College of Rheumatology Committee on Journal Publications announces the search for the position of Editor, Arthritis & Rheumatology. The official term of the next Arthritis & Rheumatology editorship is, 2019.
,